Arrhythmia Research Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Cardiovasc Pathol. 2010 Sep-Oct;19(5):316-20. doi: 10.1016/j.carpath.2009.06.003. Epub 2009 Jul 24.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) represents an inherited cardiomyopathy that manifests clinically with malignant ventricular arrhythmias, sudden cardiac death, and less commonly heart failure. The condition is characterized by replacement of the myocardium, primarily of the right ventricle, with fibrofatty tissue. Extensive fibrofatty replacement of the myocardium has been previously thought to be pathognomonic of ARVC; however, this report details two other forms of inherited cardiomyopathy, namely hypertrophic cardiomyopathy (HCM) and the PRKAG2 cardiac syndrome, that were found to have significant fibrofatty myocardial replacement at pathologic examination. This report represents the first documentation of inherited cardiomyopathies mimicking ARVC and highlights the concept that other cardiac conditions can be associated with fibrofatty replacement of the myocardium.
致心律失常性右室心肌病(ARVC)是一种遗传性心肌病,临床上表现为恶性室性心律失常、心源性猝死,以及较少见的心衰。该疾病的特征是心肌(主要是右心室)被纤维脂肪组织替代。以前认为心肌广泛纤维脂肪替代是 ARVC 的特征性表现;然而,本报告详细描述了另外两种遗传性心肌病,即肥厚型心肌病(HCM)和 PRKAG2 心脏综合征,在病理检查时发现它们有明显的纤维脂肪心肌替代。本报告代表了首例模仿 ARVC 的遗传性心肌病的记录,并强调了其他心脏疾病可能与心肌纤维脂肪替代相关的概念。